Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportInstrumentation & Data Analysis

An in vivo comparison of 5-HT1A receptor density (Bmax) and BPND using [18F]mefway

Dustin Wooten, Ansel Hillmer, Jeff Moirano, Elizabeth Ahlers, Maxim Slesarev, Todd Barnhart, Jogeshwar Mukherjee, Mary Schneider and Brad Christian
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 213;
Dustin Wooten
1University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ansel Hillmer
1University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeff Moirano
1University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Ahlers
1University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maxim Slesarev
1University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Todd Barnhart
1University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jogeshwar Mukherjee
2University of California, Irvine, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Schneider
1University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brad Christian
1University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

213

Objectives The nondisplaceable binding potential (BPND) represents an index of receptor density (Bmax), in vivo ligand-receptor affinity (1/KD), and nonspecific receptor binding (fND). Although often used as a metric for measuring disease specific changes in Bmax, several studies using different PET radioligands have shown that there is often no correlation between Bmax and BPND. The goal of this work was to examine this relation using the 5-HT1A PET ligand [18F]mefway (MEF) and carefully designed experiments to measure Bmax and in vivo dissociation constant (KDapp).

Methods Three-injection experiments, including partial saturation injections of MEF, were designed for high precision measurement of KDapp (= koff/kon) and Bmax in the 5-HT1A receptor-rich area of the mesial temporal cortex (MTC). PET experiments were conducted in six (2m,4f) anesthetized rhesus monkeys using arterial sampling to generate the input function. The “hot-cold” model was used to derive estimates of Bmax and KDapp with uncertainties calculated using generated-noise simulations. BPND measurements were performed using the Logan DVR (BPND=DVR-1) from the first injection data (high specific activity MEF and 90 minute duration) using the cerebellum as a reference region, which has shown to exhibit no measurable specific binding of MEF. BPND was regressed with KDapp, Bmax, and Bmax/KDapp.

Results The fractional uncertainties in the parameter estimates were: 6% (4-8%) for Bmax and 6% (4-11%) for KDapp. The intersubject coefficient of variation (CV=sd/mean) was 22%, 27%, and 21% (BPND,KDapp,Bmax). Regression analysis showed no significant correlation between BPND and Bmax (p=0.26) or KDapp (p=0.43). A significant correlation was found between BPND and Bmax/KDapp in the MTC (p=0.018).

Conclusions Our results from six subjects show that for MEF BPND is not a proxy of Bmax or KDapp, but a combination of the two (Bmax/KDapp), indicating each index provides a unique measure of ligand-receptor binding.

Research Support AA017706, MH086014, AG030524, AA12277, T32CA0092

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An in vivo comparison of 5-HT1A receptor density (Bmax) and BPND using [18F]mefway
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
An in vivo comparison of 5-HT1A receptor density (Bmax) and BPND using [18F]mefway
Dustin Wooten, Ansel Hillmer, Jeff Moirano, Elizabeth Ahlers, Maxim Slesarev, Todd Barnhart, Jogeshwar Mukherjee, Mary Schneider, Brad Christian
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 213;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
An in vivo comparison of 5-HT1A receptor density (Bmax) and BPND using [18F]mefway
Dustin Wooten, Ansel Hillmer, Jeff Moirano, Elizabeth Ahlers, Maxim Slesarev, Todd Barnhart, Jogeshwar Mukherjee, Mary Schneider, Brad Christian
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 213;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Instrumentation & Data Analysis

  • Assessment of Tumor Burden in Lymphoma Patients with Deauville Score 4 Disease on Post Therapy FDG PET
  • Exploring the impact of feature selection methods and classification algorithms on the predictive performance of PET radiomic ML models in lung cancer
  • Accuracy of 177Lu-DOTATATE PRRT absorbed dose estimation by reducing the imaging points
Show more Instrumentation & Data Analysis

Data Analysis & Management I: Brain Imaging

  • Noninvasive graphical analysis methods for parametric mapping of [18F]FP-CIT dynamic PET
  • Evaluation of motion correction schemes for simultaneous FDG-PET/MR studies in Alzheimer's disease
  • Automated glioma classification and segmentation using voxel-wise kinetic analysis in dynamic 18F-FET PET
Show more Data Analysis & Management I: Brain Imaging

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire